| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Finckenstein Friedrich Graf is Chief Medical Officer at IOVA. Finckenstein Friedrich Graf's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.2M at current prices.
Finckenstein Friedrich Graf has 32 Form 4 filings on record from July 2019 to June 2026, all as Chief Medical Officer at Iovance Biotherapeutics (IOVA), 2019–2026.
The 63 reported transactions were 25 option exercises, 25 tax withholdings and 13 option or other derivative awards.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
No transactions found
Try adjusting your filters or search criteria